Subcutaneous Indwelling of Vacuum Drainage in Total Knee Arthroplasty

June 5, 2009 updated by: Seoul National University Hospital

Subcutaneous Indwelling of Vacuum Drainage in Total Knee Arthroplasty: Prospective Randomized Comparisons With Intraarticular Indwelling

This prospective, randomized trial asked whether subcutaneous indwelling of vacuum drainage has advantages over intraarticular indwelling in terms of blood loss, bleeding related complications, and functional outcomes in primary total knee arthroplasty (TKA). The investigators hypothesized that the subcutaneous indwelling method would reduce blood loss with comparable bleeding-related complications and functional outcomes. The subcutaneous indwelling group demonstrated reduced blood loss with comparable prevalence of bleeding-related complications and functional outcomes. In conclusion, the investigators' study verified the efficacy and absence of risks of subcutaneous indwelling method. So the investigators propose that the subcutaneous indwelling drainage can be a good option to address the problems related to postoperative bleeding after TKA.

Study Overview

Detailed Description

There are numerous reports in the literature on drainage options after TKA, but there is no consensus. Many studies have shown no apparent advantage of drainage but routine intraarticular indwelling drainage after TKA has been extensively used to avoid complications associated with hematoma formation. It is of interest to determine if it is possible to reduce blood loss while still using drainage. So we came to think about a new and more convenient method-subcutaneous indwelling. Theoretically subcutaneous indwelling method which still has the advantages over the intraarticular indwelling method but is more convenient than drain-clamping method may be a better option. So we hypothesized that subcutaneous indwelling method of vacuum drainage has advantages over the intraarticular indwelling method.

Study Type

Interventional

Enrollment (Actual)

111

Phase

  • Phase 4

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Gyeonggi-do
      • Seongnam-si, Gyeonggi-do, Korea, Republic of, 463-707
        • Joint Reconstruction Center, Seoul National University Bundang Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

54 years to 85 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Diagnosis of primary osteoarthritis
  • primary total knee arthroplasty
  • Signed written informed consent
  • Spinal/epidural anesthesia

Exclusion Criteria:

  • Patients with coagulation disorders
  • Revision total knee arthroplasty
  • Simultaneous bilateral total knee arthroplasty
  • Diagnosis other than primary osteoarthritis
  • Patients refusing consents

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: subcutaneous group
Vacuum drainage is indwelled in subcutaneous layer
vacuum drainage is indwelled in subcutaneous layer
Other Names:
  • hemovac
Experimental: intraarticular group
Vacuum drainage is indwelled in intraarticular space
vacuum drainage is indwelled in intraarticular space
Other Names:
  • hemovac

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
blood parameters by which we can estimate blood loss , such as drained blood volume, hemoglobin and hemoglobin drop
Time Frame: 24 hours after operation
24 hours after operation

Secondary Outcome Measures

Outcome Measure
Time Frame
transfusion
Time Frame: during hospital stay
during hospital stay
wound problem
Time Frame: during hospital stay
during hospital stay
hypotension episode
Time Frame: during hospital stay
during hospital stay
functional outcome (ROM, AKS Knee score, WOMAC score, SF-36 score)
Time Frame: preoperative & postoperative 1 year
preoperative & postoperative 1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Tae Kyun Kim, MD, PhD, Joint Recontruction Center, Seoul National University Bundang hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2006

Primary Completion (Actual)

June 1, 2007

Study Completion (Actual)

June 1, 2007

Study Registration Dates

First Submitted

May 15, 2009

First Submitted That Met QC Criteria

June 5, 2009

First Posted (Estimate)

June 9, 2009

Study Record Updates

Last Update Posted (Estimate)

June 9, 2009

Last Update Submitted That Met QC Criteria

June 5, 2009

Last Verified

June 1, 2009

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Total Knee Arthroplasty

Clinical Trials on subcutaneous indwelling

Subscribe